Clene Inc.
Clene Inc. (CLNN) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CLNN · as of Sep 30, 2025
Ownership Breakdown
29
Institutional Holders
▲ 5 vs Q2
$4.72M
Total Inst. Value
▲ $2.45M vs Q2
10.31M
Shares Outstanding
freeFloat 65.87%
783,757
13F Shares Held
▲ 201,656 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CLNN largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
SCOGGIN MANAGEMENT LP pharmaceutical preparations | 250.0K | 2.63% | 2.63% | $1.51B | Nov 13, 2025 | ▲ 107.3K |
VANGUARD GROUP INC pharmaceutical preparations | 201.0K | 2.11% | 2.11% | $1.21B | Nov 7, 2025 | ▲ 12.6K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 76.0K | 79.79% | 79.79% | $457.91M | Nov 12, 2025 | ▲ 7.7K |
LUNT CAPITAL MANAGEMENT, INC. pharmaceutical preparations | 52.3K | 54.87% | 54.87% | $314.87M | Nov 12, 2025 | ▲ 1.3K |
PARSONS CAPITAL MANAGEMENT INC/RI pharmaceutical preparations | 37.2K | 39.11% | 39.11% | $224.39M | Oct 29, 2025 | ▲ 743 |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 30.4K | 31.96% | 31.96% | $183.40M | Nov 13, 2025 | NEW |
MARSHALL WACE, LLP pharmaceutical preparations | 22.7K | 23.84% | 23.84% | $136.94M | Nov 13, 2025 | NEW |
MORGAN STANLEY pharmaceutical preparations | 19.9K | 20.91% | 20.91% | $119.98M | May 27, 2026 | ▲ 1.9K |
NORTHERN TRUST CORP pharmaceutical preparations | 16.8K | 17.64% | 17.64% | $101.23M | Nov 14, 2025 | ▲ 5.3K |
SBI SECURITIES CO., LTD. pharmaceutical preparations | 15.0K | 15.78% | 15.78% | $90.53M | Nov 5, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
9
Increased
+138.8K shares9
New Positions
first time holders2
Decreased
−2.6K shares4
Sold Out
fully exitedNet shares change (top 50)
+136.2K
+138.8K / −2.6K
Net new holders
+12
9 new / 4 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CLNN insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
16
Buy transactions
14
Sell transactions
1.14
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
McLaughlin Vallerie director | May 21, 2026 | Award | 2,064 | $6.81 | $14.1K | 2.1K | Form 4 ↗ |
McLaughlin Vallerie director | May 21, 2026 | Award | 1,500 | $6.81 | $10.2K | 1.5K | Form 4 ↗ |
Desai Arjun JJ director | May 21, 2026 | Award | 2,158 | $6.81 | $14.7K | 2.2K | Form 4 ↗ |
Desai Arjun JJ director | May 21, 2026 | Award | 1,500 | $6.81 | $10.2K | 1.5K | Form 4 ↗ |
Mosca Alison director | May 21, 2026 | Award | 2,861 | $6.81 | $19.5K | 2.9K | Form 4 ↗ |
Mosca Alison director | May 21, 2026 | Award | 1,500 | $6.81 | $10.2K | 1.5K | Form 4 ↗ |
MATLIN DAVID J director | May 21, 2026 | Award | 3,659 | $6.81 | $24.9K | 3.7K | Form 4 ↗ |
MATLIN DAVID J director | May 21, 2026 | Award | 1,500 | $6.81 | $10.2K | 1.5K | Form 4 ↗ |
Jacobovitz Shalom director | May 21, 2026 | Award | 2,791 | $6.81 | $19.0K | 2.8K | Form 4 ↗ |
Jacobovitz Shalom director | May 21, 2026 | Award | 1,500 | $6.81 | $10.2K | 1.5K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Clene Inc. (CLNN) is primarily owned by institutional investors, who hold approximately 7.6% of total shares outstanding. Company insiders own approximately 34.13%, while retail and public investors account for the remaining 58.26%.
The largest institutional shareholder of Clene Inc. is SCOGGIN MANAGEMENT LP, holding approximately 250,000 shares — equal to 2.63% of outstanding shares — as of September 30, 2025.
A total of 29 institutional investors currently hold CLNN stock, with a combined institutional value of approximately $4,721,300 as of the most recent 13F filing period.
Frequently asked questions
CLNN ownershipClene Inc. (CLNN) is primarily owned by institutional investors, who hold approximately 7.6% of shares. The largest shareholder is SCOGGIN MANAGEMENT LP with a 2.63% stake. Company insiders hold 34.13%. Data sourced from SEC Form 13F as of September 30, 2025.